| increasing chloroquine resistance -- the mpumalanga lowveld story, 1990-1995. | | 1996 | 8658314 |
| in vitro susceptibilities of field isolates of plasmodium falciparum to chloroquine in mpumalanga. | | 1996 | 8823442 |
| malaria protection measures used by in-flight travelers to south african game parks. | malaria prevention in travelers depends upon dissemination of accurate information about malaria risk, prevention of mosquito bites, appropriate chemoprophylaxis use and knowledge of the symptoms of malaria. a study was undertaken of travelers to the kruger national park and private game parks in mpumalanga province, south africa to investigate travelers knowledge, of malaria, chemoprophylaxis use, and experience of adverse events. in-flight self administered questionnaires were distributed and ... | 1999 | 10575175 |
| sulfadoxine-pyrimethamine effectiveness against plasmodium falciparum malaria in mpumalanga province, south africa. | | 1999 | 10717756 |
| effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of plasmodium falciparum malaria in mpumalanga province, south africa. | quinine therapy for 7 days remains the mainstay for treating hospitalised malaria cases in south africa. however, limited resources, including available beds and staff, often result in early discharge of non-severe cases, with quinine tablets for outpatient use. the effectiveness of shorter course quinine therapy coupled with a long-acting antimalarial drug has never been established in africa, in particular in a population without malaria immunity. | 2001 | 11544977 |
| therapeutic efficacy of sulfadoxine-pyrimethamine in uncomplicated plasmodium falciparum malaria 3 years after introduction in mpumalanga. | to assess therapeutic efficacy of sulfadoxine-pyrimethamine (sp) in treatment of uncomplicated plasmodium falciparum malaria 3 years after introduction in mpumalanga, south africa. | 2001 | 11847920 |
| rapid immunochromatographic diagnosis and rolling back malaria--experiences from an african control program. | malaria is a re-emerging disease in much of africa. in response, the world health organization launched the roll back malaria (rbm) initiative. one of six key principles adopted is the early detection of malaria cases. however, the importance of definitive diagnosis and potential value of field deployment of rapid malaria tests in rbm has been largely ignored. the lowveld region of mpumalanga province, south africa, is home to a predominantly non-immune population, of approximately 850000 inhabi ... | 2001 | 14513934 |
| false detection of plasmodium falciparum sporozoites in anopheles marshallii group mosquitoes. | a study was conducted to determine the role of members of the anopheles funestus group in malaria transmission in the mpumalanga province, in the northeastern region of south africa. female anopheline mosquitoes were collected between january 1996 and november 1997 by means of human landing catches and tested for salivary gland plasmodium falciparum infections by means of the enzyme-linked immunosorbent assay (elisa) method with pf2a10 antibodies. infection rates from april and may 1997 collecti ... | 2001 | 14529083 |
| therapeutic efficacy of sulfadoxine-pyrimethamine for plasmodium falciparum malaria. | to assess the therapeutic efficacy of sulfadoxinepyrimethamine (sp) after 5 years of use as first-line treatment of uncomplicated plasmodium falciparum malaria, and thus guide the selection of artemisinin-based combination therapy in mpumalanga, south africa. | 2005 | 15931450 |
| increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. | although malaria treatment aims primarily to eliminate the asexual blood stages that cause illness, reducing the carriage of gametocytes is critical for limiting malaria transmission and the spread of resistance. | 2008 | 18471066 |